Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Overview of MicroRNAs as Biomarkers of ALS
Greig Joilin, P. Nigel Leigh, Sarah F. Newbury, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases
Julia Konovalova, Dmytro Gerasymchuk, Ilmari Parkkinen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6055-6055
Open Access | Times Cited: 175
MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease
Zahraa Alkhazaali-Ali, Sajad Sahab-Negah, Amir Reza Boroumand, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116899-116899
Open Access | Times Cited: 17
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
Namita Goyal, James Berry, Anthony J. Windebank, et al.
Muscle & Nerve (2020) Vol. 62, Iss. 2, pp. 156-166
Open Access | Times Cited: 81
The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis
Jinmeng Liu, Fenghua Zhou, Yingjun Guan, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 572-572
Open Access | Times Cited: 39
Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis
Metka Ravnik‐Glavač, Damjan Glavač
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 5, pp. 1714-1714
Open Access | Times Cited: 60
Focus on the heterogeneity of amyotrophic lateral sclerosis
Caterina Bendotti, Valentina Bonetto, Elisabetta Pupillo, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2020) Vol. 21, Iss. 7-8, pp. 485-495
Open Access | Times Cited: 55
Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis
M.E. Cicardi, Lara Marrone, Mimoun Azzouz, et al.
The EMBO Journal (2021) Vol. 40, Iss. 10
Open Access | Times Cited: 49
Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy
Silvia Bono, Marco Feligioni, Massimo Corbo
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 48
Small RNA sequencing of circulating small extracellular vesicles microRNAs in patients with amyotrophic lateral sclerosis
Jinah Kim, Canaria Park, Jung‐Joon Sung, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
A microRNA diagnostic biomarker for amyotrophic lateral sclerosis
Sandra Anne Banack, Rachael A. Dunlop, Paul Mehta, et al.
Brain Communications (2024) Vol. 6, Iss. 5
Open Access | Times Cited: 7
Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis
Greig Joilin, Elizabeth Gray, Alexander G. Thompson, et al.
Brain Communications (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 49
From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis
Giovanna Morello, Salvatore Salomone, Velia D’Agata, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 44
Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons
Marta Barbosa, Cátia Gomes, Catarina Sequeira, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 37
Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes
Mafalda Rizzuti, Valentina Melzi, Delia Gagliardi, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 25
The Role of miRNAs in Dexmedetomidine’s Neuroprotective Effects against Brain Disorders
Codrin-Constantin Burlacu, Maria Adriana Neag, Andrei-Otto Mitre, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5452-5452
Open Access | Times Cited: 25
Identification of let-7f and miR-338 as plasma-based biomarkers for sporadic amyotrophic lateral sclerosis using meta-analysis and empirical validation
Narges Daneshafrooz, Mohammad Taghi Joghataei, Mehdi Mehdizadeh, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases
Y. Ma, Lan Zhao
Behavioural Neurology (2023) Vol. 2023, pp. 1-24
Open Access | Times Cited: 16
Gene targeting in amyotrophic lateral sclerosis using causality-based feature selection and machine learning
Kyriaki Founta, Dimitra Dafou, Ειrini Kanata, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 14
Systematic review and meta-analysis of dysregulated microRNAs derived from liquid biopsies as biomarkers for amyotrophic lateral sclerosis
Hemerson Casado Gama, Mariana A. Amorós, Mykaella Andrade de Araújo, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 523-535
Open Access | Times Cited: 6
A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach
Rawiah S. Alshehri, Ahmad R. Abuzinadah, Moafaq S. Alrawaili, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10900-10900
Open Access | Times Cited: 5
Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis?
Laura Moreno‐Martínez, Ana Cristina Calvo, Marı́a Jesús Muñoz, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2759-2759
Open Access | Times Cited: 40
Circulating MyomiRs as Potential Biomarkers to Monitor Response to Nusinersen in Pediatric SMA Patients
Silvia Bonanno, Stefania Marcuzzo, Claudia Malacarne, et al.
Biomedicines (2020) Vol. 8, Iss. 2, pp. 21-21
Open Access | Times Cited: 39
Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis
Eleni Christoforidou, Greig Joilin, Majid Hafezparast
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 33
Astrocytic MicroRNA in Ageing, Inflammation, and Neurodegenerative Disease
Aimee J. Chu, Joanna M. Williams
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 20
Diagnostic Circulating miRNAs in Sporadic Amyotrophic Lateral Sclerosis
Antonella Panio, Claudia Cava, Salvatore D’Antona, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top